Mashi 2023: Uhlobo Lokufunda : Ukungenelela (Isivivinyo Somtholampilo)Ukubhaliswa Okulinganiselwe : Abahlanganyeli abangu-30Isabelo: Ayikho Imodeli Yokungenelela: Incazelo Yemodeli Yokungenela Umsebenzi Okulandelanayo: idizayini ethi "3+3" isetshenziselwa ukunquma Ubukhulu.
Isifinyezo esifushane: Ucwaningo lwe-APRIL CAR-T cell therapy yeziguli ezine-BCMA/TACI positive relapse kanye/noma refractory multiple myeloma Incazelo Eningiliziwe: Lena ingalo eyodwa, ilebula evulekile, si.
16 Mashi 2023: Ukwelashwa komdlavuza kuguqulwa ngemithi emisha ye-immunotherapeutic eqondise i-microenvironment endaweni yesimila. Amaseli e-T ane-chimeric antigen receptors (CAR) acwaningwa kabanzi.